Paramount Cosmetics Fair Value
Paramount Cosmetics fair value. Paramount Cosmetics (PARMCOS-B) average fair value is ₹2185.64 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹34.5 (+6235.2%), fair value range ₹35.71–₹12754.79. Check PARMCOS-B market capitalization to track the company's total market size over time.
Fair Value Analysis Export
PARMCOS-B Fair Value vs Current Price — Valuation Summary
PARMCOS-B average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore Paramount Cosmetics intrinsic worth to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
PARMCOS-B Fair Value Analysis — Data Sources & Coverage
Paramount Cosmetics financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Paramount Cosmetics screener.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
PARMCOS-B vs Consumer Goods Sector Peers — P/E, P/B & Market Cap
Paramount Cosmetics P/E ratio, P/B ratio and market capitalisation vs Consumer Goods sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| The Peria Karamalai Tea … | PKTEA | 57.01 | 1.61 | ₹306 |
| Berger Paints | BERGEPAINT | 43.55 | 7.67 | ₹52,750 |
| Eureka Forbes | EUREKAFORB | 38.7 | 1.52 | ₹7,020 |
| Vishwaraj Sugar Industri… | VISHWARAJ | -3.25 | 0.52 | ₹115 |
| Dabur India | DABUR | 34.73 | 5.92 | ₹66,390 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.